Hydroxychloroquine as a steroid-sparing agent in an infant with chronic urticaria.

scientific article published on 20 November 2017

Hydroxychloroquine as a steroid-sparing agent in an infant with chronic urticaria. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ANAI.2017.10.011
P932PMC publication ID5934996
P698PubMed publication ID29157861

P50authorTimothy P MoranQ57011491
P2093author name stringOnyinye I Iweala
Eveline Y Wu
Christopher Copenhaver
P2860cites workAn Update on Treatment and Management of Pediatric Systemic Lupus ErythematosusQ28074348
The role of antimalarial agents in the treatment of SLE and lupus nephritisQ37947108
The diagnosis and management of acute and chronic urticaria: 2014 update.Q38207184
The persistence of chronic spontaneous urticaria in childhood is associated with the urticaria activity scoreQ38944225
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).Q39907371
Hydroxychloroquine and surfactant protein C deficiencyQ45221878
Treatment of chronic urticaria in children with antihistamines and cyclosporine.Q50657990
Clinical features and natural history of physical urticaria in childrenQ80427079
The predictive factors for remission of chronic spontaneous urticaria in childhood: Outcome from a prospective studyQ88031458
Hydroxychloroquine prescribing and monitoring practices among Irish dermatologists and rheumatologistsQ88808317
P433issue1
P921main subjecturticariaQ187440
hydroxychloroquineQ421094
chronic urticariaQ3886240
P304page(s)102-104
P577publication date2017-11-20
P1433published inAnnals of Allergy, Asthma & ImmunologyQ13429696
P1476titleHydroxychloroquine as a steroid-sparing agent in an infant with chronic urticaria
P478volume120

Search more.